Correction: Cost of illness of chronic kidney disease in Lebanon: from the societal and third-party payer perspectives

被引：0
|
作者：
Mabel Aoun
Elie Helou
Ghassan Sleilaty
Rony M. Zeenny
Dania Chelala
机构：
[1] Saint-Joseph University,Department of Nephrology, Faculty of Medicine
[2] Saint-George Hospital,Department of Nephrology
[3] Saint-Joseph University,Department of Urology, Faculty of Medicine
[4] Saint-Joseph University,Unit of biostatistics, Faculty of Medicine
[5] Pharmacy Director,Department of Nephrology at Hotel
[6] American University of Beirut Medical Center,Dieu de France Hospital, Faculty of Medicine
[7] Saint-Joseph University,undefined
来源：
BMC Health Services Research | / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] COMPARISON OF DIAGNOSIS, ADMINISTRATION, AND TREATMENT-RELATED COST OF TARGETED RADIOPHARMACEUTICAL THERAPIES IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) FROM A THIRD-PARTY PAYER PERSPECTIVE
    Ruppert, A.
    Bassett, K.
    Luong, J.
    Chen, S.
    Patel, B.
    Robson, A.
    VALUE IN HEALTH, 2022, 25 (12) : S122 - S123
  • [32] Budget impact of dostarlimab plus carboplatin-paclitaxel for primary advanced or recurrent endometrial cancer from a third-party US payer perspective
    Lubinga, Solomon J.
    Walder, Lydia
    Burton, Mark
    Shen, Qin
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 1212 - 1221
  • [33] VALUE FOR MONEY: EVALUATING THE ECONOMIC BENEFIT OF A HYPOTHETICAL DISEASE MODIFYING THERAPY FOR ALZHEIMER'S DISEASE FROM CANADIAN PAYER AND SOCIETAL PERSPECTIVES
    Maity, T.
    Haig, J.
    Kulin, N. A.
    VALUE IN HEALTH, 2023, 26 (12) : S119 - S119
  • [34] A Cost-Effectiveness Analysis of Continuous Subcutaneous Insulin Injection versus Multiple Daily Injections in Type 1 Diabetes Patients: A Third-Party US Payer Perspective
    St Charles, Meaghan
    Lynch, Peter
    Graham, Claudia
    Minshall, Michael E.
    VALUE IN HEALTH, 2009, 12 (05) : 674 - 686
  • [35] Factors associated with costs of care in community-dwelling persons with dementia from a third party payer and societal perspective: a cross-sectional study
    S. Vandepitte
    L. Van Wilder
    K. Putman
    N. Van Den Noortgate
    S. Verhaeghe
    J. Trybou
    L. Annemans
    BMC Geriatrics, 20
  • [36] Factors associated with costs of care in community-dwelling persons with dementia from a third party payer and societal perspective: a cross-sectional study
    Vandepitte, S.
    Van Wilder, L.
    Putman, K.
    Van den Noortgate, N.
    Verhaeghe, S.
    Trybou, J.
    Annemans, L.
    BMC GERIATRICS, 2020, 20 (01)
  • [37] MANAGEMENT OF ANEMIA AMONG CHRONIC KIDNEY DISEASE PATIENTS ON HEMODIALYSIS: A STUDY OF COST OF ILLNESS
    Mateti, U., V
    Nagappa, A. N.
    Attur, R. P.
    Bairy, M.
    Nagaraju, S. P.
    Balkrishnan, R.
    VALUE IN HEALTH, 2014, 17 (03) : A292 - A292
  • [38] Cost-Effectiveness Analysis of Finerenone for Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes from Japanese Payer Perspective
    Ataru Igarashi
    Kenichi Ohara
    Hiroyuki Matsuda
    Junko Morii
    Suchitra Jagannathan
    Ronald Filomeno
    Advances in Therapy, 2025, 42 (2) : 995 - 1008
  • [39] Making Lemonade from Lemons: A Transaction Cost Economics Perspective on Third-Party Disruptions in a Multivendor Information Technology Service
    Liu, Haoyuan
    Wen, Wen
    Barua, Anitesh
    Whinston, Andrew B.
    INFORMATION SYSTEMS RESEARCH, 2024,
  • [40] COST MINIMIZATION ANALYSIS OF INSULIN GLARGINE 300 U/ML VS GLARGINE 100 U/ML FOR THE MANAGEMENT OF TYPE 2 DIABETES FROM A PRIVATE AND PUBLIC THIRD-PARTY PAYER PERSPECTIVE IN CHILE
    Russo, M.
    Bitran, R.
    Rodriguez, J. C.
    Grassi, B.
    Aguilera, P.
    VALUE IN HEALTH, 2018, 21 : S75 - S75
12345